Scientific Reports
Cure8 research brief
Why This Matters
This study links altered autophagy genes (ATG5, ATG16L1) in Crohn’s disease and ulcerative colitis with modulation by the gut bacterium Akkermansia muciniphila and its extracellular vesicles, suggesting a possible microbiome-related route to influence cellular processes involved in IBD.
For people with IBD, findings point to new basic-science directions — not proven treatments — that researchers may pursue toward microbiome-based therapies.
Who Should Pay Attention
Researchers and clinicians studying IBD mechanisms or microbiome therapies; patients and caregivers interested in experimental microbiome-based approaches; translational scientists working on probiotics or EV-based interventions.
Study Snapshot
Story typeResearch paper
Evidence typeResearch paper
Source depthJournal abstract
What To Know
This Scientific Reports study measured expression of autophagy genes ATG5 and ATG16L1 in blood/tissue from people with ulcerative colitis and Crohn’s disease and tested whether the gut bacterium Akkermansia muciniphila and its extracellular vesicles (EVs) changed those genes in inflamed Caco-2 intestinal epithelial cells.
In patient samples the authors report higher ATG5 and ATG16L1 expression in UC and CD versus controls. In the lab model, IL‑1β-induced inflammation upregulated ATG5 and downregulated ATG16L1; adding live A.
muciniphila tended to reverse those inflammation-related changes, while EVs showed a dose-dependent (biphasic) effect with higher EV doses restoring ATG16L1 more effectively. The paper presents mechanistic laboratory data suggesting A.
muciniphila and its EVs can alter autophagy-related gene expression in epithelial cells and that these genes are altered in IBD samples. This is preclinical, not a clinical trial or treatment recommendation.
Keep In Mind
Results come from gene-expression analysis of patient samples and in vitro (Caco-2 cell) experiments under inflammatory stimulation; effects in humans, clinical safety, dosing, and efficacy are not addressed in this paper. The summary is based on the article abstract (structured-content depth: abstract).
Source Details
Review the original publication for the complete reporting, methods, and context.
Research paper
Evidence type derived from source or registry metadata.
PublicationScientific Reports
AuthorsNesa Kazemifard, Maryam Farmani, Kimia Basiji +5 more
InstitutionResearch Institute for Gastroenterology and Liver Diseases
Study typeArticle
Indexed viaOpenAlex
Source typeResearch paper
PublishedOct 12, 2026, 12:00 AM
Content availableJournal abstract
This Cure8 brief is based on source text from the linked article. Cure8 is informational only and is not a substitute for professional medical advice, diagnosis, or treatment.
Scientists find a natural gut compound that helps heal the intestine - ScienceDaily
The article highlights a natural gut-microbe product (urolithin A) that may help repair the intestinal lining by activating a protective molecular pathway.
Identification of COPZ1 as a Shared Candidate Ferroptosis-Related Hub Gene in Periodontitis and Inflammatory Bowel Disease.
Researchers identified COPZ1 as a shared ferroptosis-related hub gene in Crohn’s disease, ulcerative colitis, and periodontitis, which could point to a new molecular pathway linking gut and oral inflammation and a...
A bile acid-GPBAR1 network supports anti-inflammatory and anti-fibrotic benefits of probiotics in colitis.
Fibrosis and stricturing are key problems in Crohn’s disease with limited therapies; this study identifies a microbiota–bile acid–GPBAR1 pathway by which a specific probiotic mix reduced inflammation and fibrosis in...